Keywords: آنتی ژن لوسکسی انسان; AED; antiepileptic drug; AGA; anti-gliadin antibody; EMA; endomysial antibody; HLA; human leukocyte antigen; MRI; magnetic resonance imaging; NAA/Cr; N-acetyl aspartate:creatine ratio; PHT; patients without clinical evidence of ataxia; PHTA; patients with
مقالات ISI آنتی ژن لوسکسی انسان (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: آنتی ژن لوسکسی انسان; Neuro-neutrophilic disease; Neuro-Sweet disease; Neuro-Behçet disease; Thrombosis; Human leukocyte antigen;
Keywords: آنتی ژن لوسکسی انسان; Human leukocyte antigen; Single-nucleotide polymorphism; HLA-DRA;
Keywords: آنتی ژن لوسکسی انسان; PCOS; polycystic ovary syndrome; NK; natural killer; uNK; uterine natural killer; KIRs; killer-cell immunoglobulin-like receptors; iKIR; Kir inhibitors; ITIM; tyrosine-based inhibitory motifs; aKIR; Kir activators; ITAM; tyrosine-based activation motifs;
Keywords: آنتی ژن لوسکسی انسان; Human leukocyte antigen; Eplet; Liver; Transplant; Mismatch;
Keywords: آنتی ژن لوسکسی انسان; CI; confidence interval; CMV; cytomegalovirus; Dâ; donor seronegative; EBV; Epstein-Barr virus; HLA; human leukocyte antigen; HR; hazard ratio; OR; odds ratio; PTLD; posttransplant lymphoproliferative disorder; Râ; recipient seronegative; R+; recipien
Keywords: آنتی ژن لوسکسی انسان; APC; allophycocyanin; ANOVA; analysis of variance; BBB; blood brain barrier; CNS; Central Nervous System; CD; cluster of differentiation; FCXM; flow cytometry cross match; FITC; fluorescein; FDA; food and drug administration; GLAST; glutamate aspartate tr
Keywords: آنتی ژن لوسکسی انسان; AP; Alkaline phosphatase; BA; Biliary atresa; BASM; Biliary atresia splenic malformation; CMV; Cytomegalovirus; DDT; Duodenal tube test; EHBDs; Extrahepatic biliary ducts; ERCP; Endoscopic retrograde cholangiopancreatography; GB; Gallbladder; GGT; Gamma-g
Keywords: آنتی ژن لوسکسی انسان; Vildagliptin; Drug-induced liver injury; Hypersensitivity; Covalent binding; Nucleophilic trapping agents; ALG; alogliptin; ANG; anagliptin; CRP; C-reactive protein; CYP; cytochrome P450; DILI; drug-induced liver injury; DLST; drug-induced lymphocyte stim
Keywords: آنتی ژن لوسکسی انسان; Nasopharyngeal carcinoma; Epstein-Barr virus; Immunotherapy; Cellular-based therapy; Vaccination; Head and neck cancer; DC; dendritic cell; NK; natural killer cell; CTL; cytotoxic T lymphocyte/cell; NPC; nasopharyngeal carcinoma; HLA; human leukocyte anti
Keywords: آنتی ژن لوسکسی انسان; acceptable antigen; acceptable mismatch program; human leukocyte antigen; kidney transplantation; panel reactive antibody;
Keywords: آنتی ژن لوسکسی انسان; cardiovascular progenitor cells; embryonic stem cells; heart failure; tissue engineering; CT; computed tomography; DSA; donor-specific antibody; EF; ejection fraction; ESC; embryonic stem cell; hESC; human embryonic stem cell; HLA; human leukocyte antigen
Keywords: آنتی ژن لوسکسی انسان; BG-DCs; dendritic cells matured with oncolysate-pre-loaded bacterial ghosts plus interferon gamma; BG; bacterial ghost; CFSE; carboxyfluorescein succinimidyl ester; DAMP; damage-associated molecular pattern; DC; dendritic cell; ELISPOT; enzyme-linked immu
Keywords: آنتی ژن لوسکسی انسان; aHSC; activated hepatic stellate cells; rHSC; reverted hepatic stellate cells; qHSC; quiescent hepatic stellate cells; MSCs; mesenchymal stem cells; IL-1β; interleukin-1β; IL-2; interleukin-2; IL-6; interleukin-6; IL-8; interleukin-8; TGF-β; transformi
Keywords: آنتی ژن لوسکسی انسان; cardiovascular; comorbidity; environment; gastrointestinal; genetics; immune; microbiome; neurologic; pathophysiology; rosacea; CeD; celiac disease; CVD; cardiovascular disease; GST; glutathione-S-transferase; GWAS; genome-wide association study; HLA; hum
Keywords: آنتی ژن لوسکسی انسان; physical signs; pathophysiology; treatment; BMT; Bone marrow transplantation; CyA; Cyclosporine A; HCQ; Hydroxychloroquine; HLA; Human leukocyte antigen; IL; Interleukin; IVIG; Intravenous immunoglobulin therapy; JDM; Juvenile dermatomyositis; JM; Juvenil
Keywords: آنتی ژن لوسکسی انسان; ADAM; a disintegrin and metalloproteinase; APP; amyloid precursor protein; APC; antigen presenting cell; Aβ; β-amyloid; B7-H1; B7-homolog 1; CARD; caspase activation and recruitment domain; CCR; C-C chemokine receptor; CIM; C-protein induced myositis; C
Keywords: آنتی ژن لوسکسی انسان; Docking; Epitope prediction; Human bocavirus; Human leukocyte antigen; Vaccine design;
Keywords: آنتی ژن لوسکسی انسان; Mass-spectrometry; Proteomics; Endocrinology; Children; Pediatrics; 17OHPG; 17-Hydroxyprogesterone; Apo; Apolipoprotein; CAH; Congenital Adrenal Hyperplasia; CDG; Congenital Disorders of Glycosylation; DHEAS; Dehydroepiandrosterone Sulfate; DN; Diabetic N
Keywords: آنتی ژن لوسکسی انسان; CVD; cardiovascular diseases; CCT; cardiac cell therapy; AMI; acute myocardial infarction; RA; refractory angina; CHF; chronic heart failure; BM-MNC; bone marrow mononuclear cells; SKM; skeletal myoblasts; EPC; endothelial progenitor cells; MSC; mesenchym
Keywords: آنتی ژن لوسکسی انسان; CI; confidence interval; cSCC; cutaneous squamous cell carcinoma; HLA; human leukocyte antigen; OR; odds ratio; SNP; single nucleotide polymorphism;
Keywords: آنتی ژن لوسکسی انسان; DILI; Immune-mediated; Tolerance; Antigen; Immune cells homing; DILI; drug-induced liver injury; HLA; human leukocyte antigen; APCs; antigen presenting cells; DCs; dendritic cells; LSECs; liver sinusoidal endothelial cells; KCs; Kupffer cells; APAP; aceta
Keywords: آنتی ژن لوسکسی انسان; ADME; absorption, distribution, metabolism and excretion; AFND; allele frequency net database; ALT; alanine aminotransferase; AOP; adverse outcome pathway; AOP-KB; AOP knowledge base; AST; aspartate aminotransferase; BSEP; bile salt export protein; CAR; c
Keywords: آنتی ژن لوسکسی انسان; DSA; donor-specific antibody; HCV; hepatitis C virus; HLA; human leukocyte antigen; IL-6; interleukin 6; ISDT; immunosuppressive drug treatment; LT; liver transplant(ation); NK; natural killer; Non-TOL; non-tolerant; PBMC; peripheral blood mononuclear cel
Keywords: آنتی ژن لوسکسی انسان; ATG; anti-thymocyte globulin; aGVHD; acute graft-versus-host disease; HLA; human leukocyte antigen; HSCT; haematopoietic stem cell transplantation; sIL-7R; soluble Interleukin-7 receptor; SNP; single nucleotide polymorphisms; TBI; total body irradiation;
Keywords: آنتی ژن لوسکسی انسان; AAV; ANCA-associated vasculitis; ACPA; anti-citrullinated protein antibodies; AID; autoimmune disease; AIM; autoimmune myopathies; AInfD; autoinflammatory disease; AS; ankylosing spondylitis; DZ; dizygotic; ER; endoplasmic reticulum; FMF; familial Mediter
Keywords: آنتی ژن لوسکسی انسان; Allograft tolerance; Chimerism; Hematopoietic stem cell transplantation; Donor bone marrow transplantation; Kidney transplantation; NHPs; non-human primates; MHC; major histocompatibility complex; mAb; monoclonal antibody; TBI; total body irradiation; TI;
Keywords: آنتی ژن لوسکسی انسان; BATF; basic leucine zipper transcription factor; BM; bone marrow; Bregs; regulatory B cells; BTLA; B and T lymphocyte attenuator; CFSE; carboxyfluorescein succinimidyl ester; CML; cell mediated lympholysis; CNI; calcineurin inhibitor; CPM; counts per minu
Keywords: آنتی ژن لوسکسی انسان; Donor-specific antibodies; Chronic active antibody-mediated rejection; Kidney transplantation; Transplant glomerulopathy; Treatment; ABMR; antibody-mediated rejection; Anti-IL2R-ab; anti-interleukin-2 receptor antibody; ATG; anti-thymocyte globulin; CAABM
Keywords: آنتی ژن لوسکسی انسان; Aspirin-exacerbated respiratory disease (AERD); Asthma; Aspirin (acetylsalicylic acid, ASA); Chronic rhinosinusitis with nasal polyps; Nonsteroidal antiinflammatory drugs (NSAID); Hypersensitivity; Intolerance; AERD; aspirin-exacerbated respiratory diseas
Keywords: آنتی ژن لوسکسی انسان; BBB; Blood-brain-barrier; CNS; central nervous system; GI; gastrointestinal; GWAS; genome wide association studies; HLA; Human leukocyte antigen; MHC; Major histocompatibility complex; NMDA; N-methyl-d-aspartate; SCFAs; Small chain fatty acids; Autoantige
Keywords: آنتی ژن لوسکسی انسان; guttate psoriasis; HLA-C*06:02; psoriasis; ustekinumab; BSA; body surface area; HLA; human leukocyte antigen; IL; interleukin; PGA; physician global assessment; Th; T helper;
Keywords: آنتی ژن لوسکسی انسان; HLA; human leukocyte antigen; SNP; single-nucleotide polymorphism;
Keywords: آنتی ژن لوسکسی انسان; BCVA; best corrected visual acuity; CI; cranial irradiation; CNS; central nervous system; CT; computerized tomography; CyA; cyclosporine A; f-TBI; fractionated total body irradiation; GVHD; graft versus host disease; HLA; human leukocyte antigen; HSCT; he
Keywords: آنتی ژن لوسکسی انسان; hematopoietic stem cell transplantation; incidence; leukemia; nationwide population study; vitiligo; CI; confidence interval; GVHD; graft-versus-host disease; HLA; human leukocyte antigen; HSCT; hematopoietic stem cell transplantation; ICD-10; Internation
Keywords: آنتی ژن لوسکسی انسان; CPRA; calculated panel reactive antibody; CPRAd; calculated panel reactive antibody with decimals; HLA; human leukocyte antigen; LCD; likelihood of finding a compatible donor; UNOS; United Network for Organ Sharing; Histocompatibility; Calculated panel re
Keywords: آنتی ژن لوسکسی انسان; AR; acute rejection; AUC; area under the curve; BALF; bronchoalveolar lavage fluid; BOS; bronchiolitis obliterans syndrome; CM; central memory T cells; EM; effector memory T cells; FEV1; forced expiratory volume in 1Â s; HLA; human leukocyte antigen; LTx;
Keywords: آنتی ژن لوسکسی انسان; Corticosteroids; Intravenous immunoglobulin therapy; Japanese; Stevens-Johnson syndrome; Toxic epidermal necrolysis; BSA; body surface area; DFPP; double filtration plasmapheresis; DIHS; drug-induced hypersensitivity syndrome; HLA; human leukocyte antigen
Keywords: آنتی ژن لوسکسی انسان; AMR; antibody-mediated rejection; BOS; Bronchiolitis obliterans syndrome; CDC; complement-dependent cytotoxicity; CLAD; chronic lung allograft dysfunction; DSA; donor-specific antibody; HLA; human leukocyte antigen; ISHLT; International Society for Heart
Keywords: آنتی ژن لوسکسی انسان; Vaccinations; Autoimmunity; Lymphoproliferation; Military personnel; Microarray analysis; Apoptotic self-epitopes; BCG; Bacillus Calmette-Guérin; CDC; Centers for Disease Control and Prevention; Td; tetanus/diphtheria; MMR; measles/mumps/rubella; HA; hep
Keywords: آنتی ژن لوسکسی انسان; CIT; cold ischemia time; cPRA; calculated panel-reactive antibody; DGF; delayed graft function; ECD; expanded criteria donor; EPTS; estimated posttransplant survival; ESRD; end-stage renal disease; HLA; human leukocyte antigen; KAS; kidney allocation syst
Keywords: آنتی ژن لوسکسی انسان; Hippocampus; Cytokines; Inflammation; Epilepsy; Activated microglia; ASD; Anti-Seizure Drug; AMPA; α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid; ATP; Adenosine Triphosphate; DAMP; Danger Associated Molecular Pattern; FS; Febrile Seizures; GABA; G
Keywords: آنتی ژن لوسکسی انسان; HLA; human leukocyte antigen; BTNL2; butyrophilin-like 2 gene; IL; interleukin; Th1; T helper type 1; Treg; regulatory T cells; JSSOG; Japanese Society of Sarcoidosis and Other Granulomatous Disorders; OR; odds ratio; CI; confidence interval; SD; standard
Keywords: آنتی ژن لوسکسی انسان; Human genetics; Statistical genetics; Genome-wide association study; Next-generation sequencing; Human leukocyte antigen;
Keywords: آنتی ژن لوسکسی انسان; Kidney transplantation; Human leukocyte antigen; CPRA;
Keywords: آنتی ژن لوسکسی انسان; cesarean delivery; infants; vaginal delivery; CD; Celiac disease; CELIPREV; Risk of Celiac Disease and Age at Gluten Introduction; HLA; Human leukocyte antigen; HR; Hazard ratio; MoBa; Norwegian Mother and Child; TGA2; IgA antitransglutaminase type 2;
Keywords: آنتی ژن لوسکسی انسان; AAA; anti-actin antibodies; anti-tTG; anti-tissue transglutaminase; CD; celiac disease; ELISA; enzyme-linked immunosorbent assay; EMA; endomysium antibodies; GFD; gluten-free diet; HLA; human leukocyte antigen; IECs; intestinal epithelial cells; IELs; int
Keywords: آنتی ژن لوسکسی انسان; APCs; antigen presenting cells; APM; Antigen Processing Machinery; β2-m; β2-microglobulin (β2-m, only in Table and Figures); DCs; dendritic cells; HLA; human leukocyte antigen; LCs; Langerhans cells; MHC; major histocompatibility complex; mAbs; monoclo
Keywords: آنتی ژن لوسکسی انسان; ADCC; antibody dependent cellular cytotoxicity; AML; acute myeloid leukemia; CMV; cytomegalovirus; CR; complete remission; HL; Hodgkin lymphoma; HLA; human leukocyte antigen; HLH; hemophagocytic lymphohistiocytosis; KIR; killer cell inhibitory immunoglobu
Keywords: آنتی ژن لوسکسی انسان; MDPI; Multidisciplinary Digital Publishing Institute; DOAJ; directory of open access journals; HLA; Human Leukocyte Antigen; IEDB; Immune Epitope Database; ABCpred; artificial neural network based B-cell epitope prediction; NIAID; National Institute of Al